Photodynamic Therapy for Breast Cancer and the Translational Potential of Quantum Dots
DOI:
https://doi.org/10.66104/wvz6ym64Keywords:
Breast Cancer, Photodynamic Therapy, Quantum Dots, Nanomedicine, NanotechnologyAbstract
Breast cancer remains one of the leading causes of female mortality worldwide, requiring more selective and less invasive therapeutic approaches. This study aimed to analyze the clinical landscape of Photodynamic Therapy (PDT) in breast cancer and discuss the translational potential of Quantum Dots (QDs) as photosensitive platforms. The methodology consisted of a documentary and exploratory analysis of secondary data from five interventional human studies registered on ClinicalTrials.gov, focusing on phases I and II, complemented by public SISCAN/DATASUS records for 2020–2025 and a narrative review of recent preclinical literature on QDs and PDT. The clinical records indicate initial evidence of feasibility, tolerability, and local antitumor activity in selected breast cancer settings, particularly with verteporfin; however, the studies were early-phase, small, and heterogeneous. No human clinical protocol directly combining QDs and PDT was identified. A phase I QD study (NCT04138342) was identified as an independent QD clinical protocol, but no results were posted in the registry. SISCAN records fluctuated during 2020–2025, with a peak in 2022; the 2025 value should be interpreted cautiously because the database was not fully consolidated at the time of extraction. Overall, QDs show translational potential for bioimaging, targeted delivery, and photosensitization, but clinical integration with PDT remains predominantly preclinical and requires further evaluation of toxicity, biodistribution, stability, pharmacokinetics, optical dosimetry, and safety.Downloads
References
ALVAREZ, N.; SEVILLA, A. Current advances in photodynamic therapy (PDT) and the future potential of PDT-combinatorial cancer therapies. International Journal of Molecular Sciences, [S.l.], v. 25, p. 1023, 2024. DOI: https://doi.org/10.3390/ijms25021023. Disponível em: Acesso em: 9 abr. 2025. DOI: https://doi.org/10.3390/ijms25021023
ANJUSHA, A. J. et al. Multifunctional amino-functionalized graphene quantum dots encapsulated in conversion nanoparticles for photodynamic therapy and X-ray CT imaging. Inorganic Chemistry Communications, v. 149, p. 110428, 2023. DOI: https://doi.org/10.1016/j.inoche.2023.110428
BOURANG, S.; NORUZPOUR, M.; JAHANBAKHSH GODEKAHRIZ, S. et al. Aplicação de nanopartículas no tratamento do câncer de mama: uma revisão sistemática. Naunyn-Schmiedeberg's Archives of Pharmacology, v. 397, p. 6459–6505, 2024. DOI: https://doi.org/10.1007/s00210-024-03082-y DOI: https://doi.org/10.1007/s00210-024-03082-y
BRASIL. Ministério da Saúde. Departamento de Informática do SUS – DATASUS. Sistema de Informação do Câncer (SISCAN): indicadores nacionais de citologia de mama – Brasil (2020–2025). Brasília: Ministério da Saúde, 2025. Disponível em: https://datasus.saude.gov.br/. Acesso em: 23 out. 2025.
CLINICALTRIALS.GOV. Cutaneous Lesions in Patients with Breast Cancer Treated with Photodynamic Therapy (CLIPT) (NCT02939274). Bethesda: U.S. National Library of Medicine, 2025. Disponível em: https://clinicaltrials.gov/study/NCT02939274. Acesso em: 23 out. 2025.
CLINICALTRIALS.GOV. Photodynamic Therapy System for Patients with Refractory/Unresponsive Solid Tumors (NCT00028405). Bethesda: U.S. National Library of Medicine, 2025. Disponível em: https://clinicaltrials.gov/study/NCT00028405. Acesso em: 23 out. 2025.
CLINICALTRIALS.GOV. Safety Study Using Photodynamic Therapy Light in Patients with Chest-Wall Progression of Breast Cancer (NCT00862901). Bethesda: U.S. National Library of Medicine, 2025. Disponível em: https://clinicaltrials.gov/study/NCT00862901. Acesso em: 23 out. 2025.
CLINICALTRIALS.GOV. Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast Cancer (NCT04138342). Bethesda: U.S. National Library of Medicine, 2025. Disponível em: https://clinicaltrials.gov/study/NCT04138342. Acesso em: 23 out. 2025.
CLINICALTRIALS.GOV. Treatment of Primary Breast Cancer Using Photodynamic Therapy (NCT02872064). Bethesda: U.S. National Library of Medicine, 2025. Disponível em: https://clinicaltrials.gov/study/NCT02872064. Acesso em: 23 out. 2025.
GUNAYDIN, G.; GEDIK, M. E.; AYAN, S. Photodynamic therapy for the treatment and diagnosis of cancer – a review of the current clinical status. Frontiers in Chemistry, v. 9, p. 686303, 2021. DOI: https://doi.org/10.3389/fchem.2021.686303. DOI: https://doi.org/10.3389/fchem.2021.686303
INSTITUTO NACIONAL DE CÂNCER JOSÉ ALENCAR GOMES DA SILVA (INCA). Estimativa 2023: incidência de câncer no Brasil. Rio de Janeiro: INCA, 2023. Disponível em: https://www.inca.gov.br/estimativa. Acesso em: 23 out. 2025. DOI: https://doi.org/10.32635/2176-9745.RBC.2000v46n1.3398
JI, B.; WEI, M.; YANG, B. Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy. Theranostics, [S.l.], v. 12, n. 1, p. 434-458, 2022. DOI: https://doi.org/10.7150/thno.67300. Disponível em: https://doi.org/10.7150/thno.67300. Acesso em: 9 abr. 2025. DOI: https://doi.org/10.7150/thno.67300
JOVANOVIĆ, S. et al. Lights and dots toward therapy—carbon-based quantum dots as novel agents for photodynamic therapy. Pharmaceutics, v. 15, n. 4, p. 1170, 2023. DOI: https://doi.org/10.3390/pharmaceutics15041170
KARAGIANNI, A. et al. Application of carbon-based quantum dots in photodynamic therapy. Carbon, v. 203, p. 273-310, 2023. DOI: https://doi.org/10.1016/j.carbon.2022.11.026
KOLARIKOVA, M. et al. Photodynamic therapy: innovative approaches for antibacterial and anticancer treatments. Medicinal Research Reviews, v. 43, n. 4, p. 717-774, 2023. DOI: https://doi.org/10.1002/med.21935
LAKATOS, E. M.; MARCONI, M. A. Metodologia do trabalho científico: procedimentos básicos, pesquisa bibliográfica, projeto e relatório, publicações e trabalhos científicos. 6. ed. São Paulo: Atlas, 2001.
LI, Y. et al. Graphene quantum dots modified upconversion nanoparticles for photodynamic therapy. International Journal of Molecular Sciences, v. 23, n. 20, p. 12558, 2022. DOI: https://doi.org/10.3390/ijms232012558
MAGAELA, N. B. et al. Nitrogen-doped graphene quantum dot nanohybrids decorated with Sn(IV) porphyrin-biotin for photodynamic therapy. Polyhedron, v. 213, p. 115624, 2022. DOI: https://doi.org/10.1016/j.poly.2021.115624
MONTASERI, H.; KRUGER, C. A.; ABRAHAMSE, H. Inorganic nanoparticles applied for active targeted photodynamic therapy of breast cancer. Pharmaceutics, [S.l.], v. 13, p. 296, 2021. DOI: https://doi.org/10.3390/pharmaceutics13030296.
Disponível em: https://doi.org/10.3390/pharmaceutics13030296. Acesso em: 9 abr. 2025. DOI: https://doi.org/10.3390/pharmaceutics13030296
NICULESCU, A.-G.; GRUMEZESCU, A. M. Photodynamic therapy — an up-to-date review. Applied Sciences, v. 11, n. 8, p. 3626, 2021. DOI: https://doi.org/10.3390/app11083626 DOI: https://doi.org/10.3390/app11083626
RAMACHANDRAN, P. et al. N-doped graphene quantum dots/titanium dioxide nanocomposites: A study of ROS formation mechanisms, cytotoxicity and photodynamic therapy. Biomedicines, v. 10, n. 2, p. 421, 2022. DOI: https://doi.org/10.3390/biomedicines10020421
UPRETY, B.; ABRAHAMSE, H. Semiconductor quantum dots for photodynamic therapy: Avanços recentes. Frontiers in Chemistry, v. 10, p. 946574, 2022. DOI: https://doi.org/10.3389/fchem.2022.946574
Published
Issue
Section
License
Copyright (c) 2026 José Adriell Ramos dos Passos, Glória Rayane Soares Silva, Maria Clarice de Melo Silva, Maria Luiza Alves dos santos, Maria Clara Lima Siqueira, Luiz Henrique de Oliveira Filho, Stephany Lorena Barbosa das Neves, Ludymila Mimoso de Moura, Karen Loraine Macena Santos

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in this journal agree to the following terms:
Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License, which permits the sharing of the work with proper acknowledgment of authorship and initial publication in this journal;
Authors are authorized to enter into separate, additional agreements for the non-exclusive distribution of the version of the work published in this journal (e.g., posting in an institutional repository or publishing it as a book chapter), provided that authorship and initial publication in this journal are properly acknowledged, and that the work is adapted to the template of the respective repository;
Authors are permitted and encouraged to post and distribute their work online (e.g., in institutional repositories or on their personal websites) at any point before or during the editorial process, as this may lead to productive exchanges and increase the impact and citation of the published work (see The Effect of Open Access);
Authors are responsible for correctly providing their personal information, including name, keywords, abstracts, and other relevant data, thereby defining how they wish to be cited. The journal’s editorial board is not responsible for any errors or inconsistencies in these records.
PRIVACY POLICY
The names and email addresses provided to this journal will be used exclusively for the purposes of this publication and will not be made available for any other purpose or to third parties.
Note: All content of the work is the sole responsibility of the author and the advisor.
